AstraZeneca Expands Cancer Treatments With Fusion Buy

Mar 19, 2024 | Uncategorized

AstraZeneca is buying Fusion Pharmaceuticals for an initial sum of $2 billion as part of a plan to accelerate the development of next-generation radioconjugates to treat cancer.

Translate »
Contactar
1
Scan the code
Hola👋
¿Cómo podemos ayudarte?